[Neurohistoplasmosis and cutaneous leishmaniasis in an immunocompetent patient]

Daniel E Calfunao1, María M Schinchirimini2, Adrián Morales1

  • 1Servicio de Infectología, Hospital Provincial Neuquén Dr. Castro Rendón, Neuquén, Argentina.

Medicina
|September 6, 2019
PubMed

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
801
Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain06:44

Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain

A demonstration of the bedside test for cutaneous allodynia and its clinical...
20.3K
Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function11:35

Dual-mode Imaging of Cutaneous Tissue Oxygenation and Vascular Function

A dual-mode imaging system was developed for non-contact assessment of cutaneous tissue oxygenation and vascular...
16.9K
Bioluminescence Imaging of an Immunocompetent Mouse Model for Glioblastoma02:28

Bioluminescence Imaging of an Immunocompetent Mouse Model for Glioblastoma

Source: Clark, A.J., et al. Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma. J. Vis. Exp. (2016)This video demonstrates bioluminescence imaging to track glioblastoma progression in an immunocompetent mouse model, using luciferase-expressing tumor cells and luciferin to quantify tumor growth...
379
Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma09:17

Bioluminescence Imaging of an Immunocompetent Animal Model for Glioblastoma

GL261 glioma cells provide a useful immunocompetent animal model of glioblastoma. The goals of this protocol are to demonstrate proper techniques for monitoring intracranial tumor growth using in vivo bioluminescence imaging, and to verify the utility of luciferase-modified GL261 cells for studying tumor immunology and immunotherapeutic approaches for treating...
15.4K
Intrabronchial Instillation of Streptococcus pneumoniae in Immunocompetent Rodent Models04:46

Intrabronchial Instillation of Streptococcus pneumoniae in Immunocompetent Rodent Models

This video demonstrates the establishment of lung infection in an immunocompetent rodent model via intubation and installation of bacterial suspensions into lung lobes. This model enables antibacterial efficacy studies in immunocompetent...
528